Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrochlorothiazide, quantity: 25 mg; telmisartan, quantity: 80 mg - tablet, multilayer - excipient ingredients: microcrystalline cellulose; sodium hydroxide; maize starch; magnesium stearate; povidone; sodium starch glycollate type a; lactose monohydrate; meglumine; mannitol; iron oxide yellow - telmisartan hct mylan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - telmisartan, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: meglumine; sodium stearylfumarate; mannitol; sodium hydroxide; magnesium stearate; povidone; lactose monohydrate; purified water; iron oxide red - telmisartan hct gh is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: meglumine; povidone; polysorbate 80; sodium hydroxide; magnesium stearate; mannitol; purified water - 1) treatment of hypertension,2) prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: meglumine; povidone; sodium hydroxide; magnesium stearate; mannitol - telmisartan mylan is indicated for:,? treatment of hypertension,? prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium hydroxide; mannitol; sodium stearylfumarate; meglumine; magnesium stearate; povidone - apo-telmisartan is indicated for:,treatment of hypertension,prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; mannitol; sodium hydroxide; magnesium stearate; meglumine - telmisartan apel is indicated for: -treatment of hypertension -prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; mannitol; sodium hydroxide; magnesium stearate; meglumine - telmisartan alsa is indicated for: -treatment of hypertension -prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; mannitol; sodium hydroxide; magnesium stearate; meglumine - telmisartan ch is indicated for:- treatment of hypertension - prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; mannitol; sodium hydroxide; magnesium stearate; meglumine - telmisartan ap is indicated for: -treatment of hypertension -prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; mannitol; sodium hydroxide; magnesium stearate; meglumine - telmisartan agl is indicated for: - treatment of hypertension -prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)